Levi & Korsinsky Reminds Shareholders of an Investigation into Pliant Therapeutics, Inc. (PLRX) Regarding Potential Securities Fraud Allegations
NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ...
Le Lézard9h
PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pliant Therapeutics, Inc. ("Pliant" or "the Company") for ...
TD Cowen Keeps Their Buy Rating on Pliant Therapeutics (PLRX)
TD Cowen analyst Ritu Baral maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today. The company’s shares closed last ...